CCEL
Cryo-Cell International Inc.
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Cryo-Cell International (CCEL) Stock: Buy, Sell, or Hold?
$5.40
+0.26 (+5.06%)
▲
5d:
+9.09%
30d:
+30.12%
90d:
+36.36%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (32%)
Quality Score
42/100
Position
EXTENDED
30-Day Fair Range
$4.18 – $5.15
Position: EXTENDED
Forward P/E & Valuation
270.0x
STRETCHED
vs 195.1x historical avg
Wall Street Target
$8.50
+57.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.75 / $5.44
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CCEL shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $5.40, which is considered extended relative to its 30-day fair value range of $4.18 to $5.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 270.0) compared to its historical average (195.1). At these levels, the market is pricing in 11.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CCEL is in a strong uptrend. The price is approaching resistance at $5.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: CCEL scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+57.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCEL is in a strong uptrend. The price is approaching resistance at $5.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: CCEL scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+57.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.18 -
$5.15
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
32.4%
Trading Range & Key Levels
30-Day Trading Range
$4.18 -
$5.15
Current vs Trading Range
EXTENDED
Support Level
$4.75
Resistance Level
$5.44
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 57.4% below Wall St target ($8.50)
- NEUTRAL: Trading at premium valuation - market expects 11.4% growth which is achievable
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
270.00
Wall Street Target
$8.50
(+57.4%)
Earnings Growth (YoY)
75.1%
Profit Margin
-6.2%
Valuation Premium vs History
+11.4% premium
PE vs Historical
270.0 vs 195.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.4%
(market-implied from PE analysis)
1-Year Target
$6.02
(+11%)
2-Year Target
$6.70
(+24%)
3-Year Target
$7.47
(+38%)
3-Yr Target (if PE normalizes)
(PE: 270→195)
PE COMPRESSION
$5.39
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 270.0, Growth: -81.8%)
$3.94
(+-27%)
Base:
(SPY PE: 19.9, Growth: -81.8%)
$0.29
(-95%)
Bear:
(PE: 16.9, Growth: -81.8%)
$0.25
(-95%)
Share CCEL Analysis
Share this live CCEL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 13, 2026 6:12 AM ET
Data refreshes hourly during market hours. Next update: 7:12 AM
Data refreshes hourly during market hours. Next update: 7:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 39 SELL |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 31 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 45 HOLD |
|
PNTG
Pennant Group Inc |
STRONG BUY
7 analysts |
$48 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CCEL Research Pages
